Quoin Pharmaceuticals (NASDAQ:QNRX) Stock Price & Analysis

–

USD

–(–)

Open

$4.47

Prev. Close

$6.90

High

$4.83

Low

$4.33

Company Profile

Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment. The organization maintains its operational base in Ashburn, Virginia.

CEOMichael Myers

SectorHealthcare

IndustryBiotechnology

Employees4

IPO DateAug 1, 2016

ExchangeNASDAQ

Exchange NameNASDAQ Capital Market

CurrencyUSD

Headquarters & Contact

Address42127 Pleasant Forest Court

City / State / ZIPAshburn, VA, 20148-7349

CountryUnited States

Phone703 980 4182

Websitehttps://quoinpharma.com

Quoin Pharmaceuticals, Ltd.

Company Profile

Recently from Cashu